MBNL1 and myotonic dystrophy type 1: Indeed, treatment of HSALR mice (mouse model for DM1) with CAG25 resulted in a significant reduction of RNA foci, reduction of CUGexp RNA, redistribution of MBNL1, rescue of missplicing and reduction of myotonia levels.